Phase I study of LZM005, a HER2 antibody, as monotherapy or in combination with trastuzumab and docetaxel in patients with HER2-positive metastatic breast cancer.

被引：1
|
作者：
Xue, Cong
Yao, Herui
Lin, Ying
An, Xin
Chen, Meiting
Dong, Yugang
Li, Su
Shi, Yanxia
机构：
[1] Sun Yat Sen Univ, Canc Ctr, Dept Med Oncol, Guangzhou, Peoples R China
[2] State Key Lab Oncol South China, Guangzhou, Peoples R China
[3] Collaborat Innovat Ctr Canc Med, Guangzhou, Peoples R China
[4] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Oncol, Guangdong Prov Key Lab Malignant Tumor Epigenet &, Guangzhou, Peoples R China
[5] Sun Yat Sen Univ, Affiliated Hosp 1, Guangzhou, Peoples R China
[6] Sun Yat Sen Univ, Ctr Canc, Guangzhou, Peoples R China
[7] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Breast Surg, Guangzhou, Peoples R China
[8] Sun Yat Sen Univ, Ctr Canc, Dept Med Oncol, Guangzhou, Peoples R China
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 15期
关键词：
D O I：
10.1200/JCO.2021.39.15_suppl.1042
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
1042
引用
下载
收藏
页数：4
相关论文
共 50 条
  • [21] Phase I/II trial of ruxolitinib in combination with trastuzumab in metastatic HER2 positive breast cancer
    Kearney, Matthew
    Franks, Lauren
    Lee, Shing
    Tiersten, Amy
    Makower, Della F.
    Cigler, Tessa
    Mundi, Prabhjot
    Chi, Dow-Chung
    Goel, Anupama
    Klein, Pam
    Andreopoulou, Eleni
    Sparano, Joseph
    Trivedi, Meghna
    Accordino, Melissa
    Califano, Andrea
    Hershman, Dawn L.
    Silva, Jose
    Kalinsky, Kevin
    BREAST CANCER RESEARCH AND TREATMENT, 2021, 189 (01) : 177 - 185
  • [22] Trastuzumab as a preoperative monotherapy does not inhibit HER2 downstream signaling in HER2-positive breast cancer
    Lion, Maeva
    Harle, Alexandre
    Salleron, Julia
    Ramacci, Carole
    Campone, Mario
    Merlin, Jean-Louis
    ONCOLOGY LETTERS, 2016, 12 (03) : 2028 - 2032
  • [23] Phase I and pharmacokinetic study of trastuzumab emtansine in Japanese patients with HER2-positive metastatic breast cancer
    Yamamoto, Harukaze
    Ando, Masashi
    Aogi, Kenjiro
    Iwata, Hiroji
    Tamura, Kenji
    Yonemori, Kan
    Shimizu, Chikako
    Hara, Fumikata
    Takabatake, Daisuke
    Hattori, Masaya
    Asakawa, Takashi
    Fujiwara, Yasuhiro
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2015, 45 (01) : 12 - 18
  • [24] A phase 1 study of vinflunine in combination with trastuzumab for the treatment for HER2-positive metastatic breast cancer
    Paridaens, R.
    Rixe, O.
    Pinel, M. C.
    Wildiers, H.
    Zorza, G.
    Ferre, P.
    Roche, H.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 70 (04) : 503 - 511
  • [25] Phase Ib study of pembrolizumab in combination with trastuzumab emtansine for metastatic HER2-positive breast cancer
    Waks, Adrienne G.
    Keenan, Tanya E.
    Li, Tianyu
    Tayob, Nabihah
    Wulf, Gerburg M.
    Richardson, Edward T.
    Attaya, Victoria
    Anderson, Leilani
    Mittendorf, Elizabeth A.
    Overmoyer, Beth
    Winer, Eric P.
    Krop, Ian E.
    Agudo, Judith
    Van Allen, Eliezer M.
    Tolaney, Sara M.
    JOURNAL FOR IMMUNOTHERAPY OF CANCER, 2022, 10 (10)
  • [26] A phase II study of bevacizumab in combination with vinorelbine and trastuzumab in HER2-positive metastatic breast cancer
    Lin, N. U.
    Seah, D. S.
    Gelman, R.
    Desantis, S.
    Mayer, E. L.
    Isakoff, S.
    DiPiro, P.
    Krop, I. E.
    Come, S. E.
    Weckstein, D.
    Winer, E. P.
    Burstein, H. J.
    BREAST CANCER RESEARCH AND TREATMENT, 2013, 139 (02) : 403 - 410
  • [27] A phase II study of bevacizumab in combination with vinorelbine and trastuzumab in HER2-positive metastatic breast cancer
    N. U. Lin
    D. S. Seah
    R. Gelman
    S. Desantis
    E. L. Mayer
    S. Isakoff
    P. DiPiro
    I. E. Krop
    S. E. Come
    D. Weckstein
    E. P. Winer
    H. J. Burstein
    Breast Cancer Research and Treatment, 2013, 139 : 403 - 410
  • [28] A phase 1 study of vinflunine in combination with trastuzumab for the treatment for HER2-positive metastatic breast cancer
    R. Paridaens
    O. Rixe
    M. C. Pinel
    H. Wildiers
    G. Zorza
    P. Ferré
    H. Roche
    Cancer Chemotherapy and Pharmacology, 2012, 70 : 503 - 511
  • [29] A PHASE 2 STUDY OF TRASTUZUMAB EMTANSINE IN JAPANESE PATIENTS WITH HER2 POSITIVE METASTATIC BREAST CANCER
    Takahashi, S.
    Kashiwaba, M.
    Takao, S.
    Ito, Y.
    Doihara, H.
    Rai, Y.
    Matsubara, M.
    Kanatani, K.
    Masuda, N.
    ANNALS OF ONCOLOGY, 2013, 24 : 20 - 20
  • [30] Vinflunine in combination with trastuzumab for treatment of HER2-positive metastatic breast cancer
    Paridaens, R., Sr.
    Wildiers, H.
    Dalenc, F.
    Rixe, O.
    Cadic, V.
    Pinel, M.
    Roche, H.
    JOURNAL OF CLINICAL ONCOLOGY, 2007, 25 (18)
12345